The National Blood Clot Alliance (NBCA) is pleased to introduce a new resource focused on interventional treatment options for deep vein thrombosis (DVT) – a blood clot in one of the large veins, usually in a person’s leg or arm. This new resource, developed by NBCA in collaboration with members of its prestigious Medical & Scientific Advisory Board, was made possible through an unrestricted educational grant from Boston Scientific.
“We are thankful for the opportunity provided by the generosity of Boston Scientific, a global leader in medical technology, to share this important information about interventional treatment options for DVT, and we look forward to further expanding this important partnership with them in the future,” says NBCA CEO Randy Fenninger.
When a DVT forms, it can partially or completely block the flow of blood through the vein. If a DVT is not treated, it can move or break off and travel to the lungs. A blood clot in the lungs – called a pulmonary embolism or PE – is life-threatening.
There are a spectrum of blood clot treatment options, depending on a person’s specific diagnosis and medical need. Anticoagulant injections and oral anticoagulant medications are commonly prescribed when DVT is diagnosed. When more aggressive treatment is needed, such as when a DVT is very large, blocks major veins, or produces severe pain and swelling of the limb, interventional treatment may sometimes be helpful in reducing the severity of symptoms. These interventional treatments also can be used when a person diagnosed with a DVT does not respond well to anticoagulation therapy.
“Every year, an estimated 900,000 Americans are affected by DVT, and among those, one-half will have long-term complications such as swelling, and pain in the affected limb,” said Jeff Mirviss, president, peripheral interventions, Boston Scientific. “That is why we are pleased to partner with the National Blood Clot Alliance in developing an educational resource dedicated to building awareness about minimally invasive treatment options used by clinicians to treat deep vein thrombosis so that patients can take an active role in seeking out the best options for their care.”
Click here to read this new information about interventional treatment options for DVT.
The National Blood Clot Alliance is focused on improving public awareness about DVT and PE, and providing support and helpful information to those affected by blood clots. Earlier this year, the organization’s website and several of its other educational resources were chosen for use in a new compendium of venous thromboembolism resources developed by The Joint Commission, a nonprofit organization that accredits and certifies thousands of healthcare organizations and programs nationwide.
Learn more about the Basics of Blood Clots here.
Join NBCA’s Online Support Group and Discussion Community here.
Contact email@example.com with questions or comments.